Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
Paul Thompson MD
Paul D. Thompson MD Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
See All Experts
featured
Published in Cardiology and
2 other channels

Expert Opinion / Interview · May 21, 2018

Rationale and Contemporary Options for High Intensity Cholesterol Treatment: PCSK-9 Inhibitors

Jennifer Caudle DO
Peter Libby MD
Interview with
Peter Libby MD

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Libby MD

Further Reading

Related Videos